Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Colon Cancer treatment details. Chemotherapy. University General Hospital of Heraklion, Heraklion, Greece

Survival: 19.5 months
Toxicity Grade: 5
Treatments: Chemotherapy
Drugs: Adrucil
Country: Greece
City/State/Province: Heraklion
Hospital: University General Hospital of Heraklion
Journal: Link
Date: 2/2006

Patients: This Phase III study involved 285 patients with metastatic colorectal cancer. The patients were randomly divided into two groups. Group A had 146 patients (82 men, 61 women) with a median age of 66 years. Metastatic sites included liver and lung, and 60% of patients in both arms had two or more metastatic sites.

Treatment: Group A received the FOLFIRI treatment protocol consisting of two chemotherapeutic agents: irinotecan and 5-FU/LV.

Toxicity: For Group A, two patients died of febrile neutropenia during treatment. Other grade 3-4 toxicities included neutropenia, alopecia, diarrhea, nausea/vomiting, thrombocytopenia and mucositis.

Results: The median overall survival was 19.5 months for Group A and 21.5 months for Group B; this difference was not statistically significant. Group A had 5 complete response, 44 partial responses, and 39 with stable disease. Group B had 9 complete response, 50 partial responses and 43 with stable disease. The authors concluded, "the present study failed to demonstrate any survival advantage of the FOLFOXIRI over the FOLFIRI regimen."

Correspondence: Dr. J. Souglakos

E-mail to a Friend Email Physician More Information